Semin intervent Radiol 2015; 32(04): 384-387
DOI: 10.1055/s-0035-1564707
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Endovascular Management of Acute Pulmonary Embolism Using the Ultrasound-Enhanced EkoSonic System

Mark J. Garcia
1   Department of Interventional Radiology, Christiana Care Health Services, Newark, Delaware
› Author Affiliations
Further Information

Publication History

Publication Date:
10 November 2015 (online)

Abstract

Acute, symptomatic pulmonary embolism (PE) in the massive and submassive categories continues to be a healthcare concern with significant risk for increased morbidity and mortality. Despite increased awareness and venous thromboembolism prophylaxis, endovascular treatment is still an important option for many of these patients. There are a variety of techniques and devices used for treating PE, but none have been evaluated as extensively as the EkoSonic endovascular system that is also currently the only FDA-approved device for the treatment of pulmonary embolism. This article describes the use of the EkoSonic device for this patient population.

 
  • References

  • 1 Heit JA, O'Fallon WM, Petterson TM , et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 2002; 162 (11) 1245-1248
  • 2 Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med 2011; 171 (9) 831-837
  • 3 Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton III LJ. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158 (6) 585-593
  • 4 Rathbun S. Cardiology patient pages. The Surgeon General's call to action to prevent deep vein thrombosis and pulmonary embolism. Circulation 2009; 119 (15) e480-e482
  • 5 Flinterman LE, van Hylckama Vlieg A, Cannegieter SC, Rosendaal FR. Long-term survival in a large cohort of patients with venous thrombosis: incidence and predictors. PLoS Med 2012; 9 (1) e1001155
  • 6 Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W ; Management Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002; 347 (15) 1143-1150
  • 7 Piazza G, Goldhaber SZ. Fibrinolysis for acute pulmonary embolism. Vasc Med 2010; 15 (5) 419-428
  • 8 Kennedy RJ, Kenney HH, Dunfee BL. Thrombus resolution and hemodynamic recovery using ultrasound-accelerated thrombolysis in acute pulmonary embolism. J Vasc Interv Radiol 2013; 24 (6) 841-848
  • 9 Kucher N, Boekstegers P, Müller OJ , et al. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation 2014; 129 (4) 479-486
  • 10 Piazza G, Goldhaber S , et al. A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism. The SEATLLE II Study. J Am Coll Cardiol Intv 2015; 8 (10) 1382-1392
  • 11 EKoSonic® MACH 4e. http://www.ekoscorp.com/ekosonic_endovascular_peripheral.htm#EKOS_in_vitro_data_on_file_ . Accessed June 2015
  • 12 Francis CW, Blinc A, Lee S, Cox C. Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Ultrasound Med Biol 1995; 21 (3) 419-424
  • 13 Soltani A, Volz KR, Hansmann DR. Effect of modulated ultrasound parameters on ultrasound-induced thrombolysis. Phys Med Biol 2008; 53 (23) 6837-6847
  • 14 Braaten JV, Goss RA, Francis CW. Ultrasound reversibly disaggregates fibrin fibers. Thromb Haemost 1997; 78 (3) 1063-1068
  • 15 Soltani A, Singhal R, Garcia JL, Raju NR. Absence of biological damage from prolonged exposure to intravascular ultrasound: a swine model. Ultrasonics 2007; 46 (1) 60-67